Raymond James Financial Services Advisors’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-12,641
Closed -$15K 3121
2020
Q3
$15K Hold
12,641
﹤0.01% 2834
2020
Q2
$15K Sell
12,641
-400
-3% -$370 ﹤0.01% 2776
2020
Q1
$11K Hold
13,041
﹤0.01% 2386
2019
Q4
$13K Hold
13,041
﹤0.01% 2819
2019
Q3
$18K Sell
13,041
-1,600
-11% -$2.26K ﹤0.01% 2754
2019
Q2
$22K Sell
14,641
-583
-4% -$901 ﹤0.01% 2786
2019
Q1
$23K Buy
15,224
+4,163
+38% +$6.35K ﹤0.01% 2746
2018
Q4
$16K Hold
11,061
﹤0.01% 2526
2018
Q3
$20K Hold
11,061
﹤0.01% 2765
2018
Q2
$20K Hold
11,061
﹤0.01% 2725
2018
Q1
$22K Hold
11,061
﹤0.01% 2491
2017
Q4
$12K Sell
11,061
-5,000
-31% -$5.11K ﹤0.01% 2518
2017
Q3
$18K Sell
16,061
-900
-5% -$1.02K ﹤0.01% 2515
2017
Q2
$22K Buy
16,961
+2,000
+13% +$2.84K ﹤0.01% 2461
2017
Q1
$29K Sell
14,961
-9,061
-38% -$19.2K ﹤0.01% 2344
2016
Q4
$51K Buy
+24,022
New +$50.1K ﹤0.01% 2238

Other funds holding MBII

Raymond James Financial Services Advisors's MBII Position: Q4 2020 in Review

Raymond James Financial Services Advisors sold out of Marrone Bio Innovations, Inc. (MBII) in Q4 2020, closing a stake of 12,641 shares — an estimated $15K sold.

Raymond James Financial Services Advisors first reported a position in MBII in Q4 2016 and held it in 16 quarters. The position peaked at $51K in Q4 2016. 62 funds tracked by Wall St. Rank hold MBII as of Q4 2020.

  • Raymond James Financial Services Advisors reported no remaining Marrone Bio Innovations, Inc. position as of Q4 2020 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 12,641 Marrone Bio Innovations, Inc. shares in Q4 2020, an estimated $15K.
  • Raymond James Financial Services Advisors first reported a position in Marrone Bio Innovations, Inc. in Q4 2016 and held it in 16 quarters.
  • Raymond James Financial Services Advisors's Marrone Bio Innovations, Inc. position peaked at $51K in Q4 2016.
  • 62 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q4 2020.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.